Quick Answer
Context Therapeutics Inc. reported Total Assets of $68.49 million for fiscal year 2025.
Context Therapeutics Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $68.49M | -30.2% |
| 2024 | $98.13M | +510.9% |
| 2023 | $16.06M | -57.7% |
| 2022 | $37.97M | -26.0% |
| 2021 | $51.31M | +10878.2% |
| 2020 | $467.3K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $79.23M | -8.2% | -9.1% |
| June 30, 2025 | $87.15M | -15.1% | -6.3% |
| March 31, 2025 | $92.97M | +741.2% | -5.3% |
| December 31, 2024 | $98.13M | +510.9% | +13.7% |
| September 30, 2024 | $86.33M | +275.5% | -15.9% |
| June 30, 2024 | $102.71M | +270.0% | +829.4% |
| March 31, 2024 | $11.05M | -65.4% | -31.2% |
| December 31, 2023 | $16.06M | -57.7% | -30.1% |
- Context Therapeutics Inc. showed a decrease of -30.2% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Context Therapeutics Inc.’s total assets has grown by 14556.1% (from $467.3 thousand to $68.49 million).
- The most recent figure is from Context Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: